Economics Of Irreparable Harm In Pharma Patent Litigation
The Drug Price Competition and Patent Term Restoration Act of 1984, also known as the Hatch-Waxman Act, allows generic products to be launched while the patent(s) on the equivalent branded drug...To view the full article, register now.
Already a subscriber? Click here to view full article